Report Detail
Global Dendritic Cell Cancer Vaccine Market Professional Survey Report 2019
- RnM3727725 |
- 05 September, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells.
The global Dendritic Cell Cancer Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Dendritic Cell Cancer Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dendritic Cell Cancer Vaccine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Dendritic Cell Cancer Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Dendritic Cell Cancer Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Medigene
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation (Dendreon)
Elios Therapeutics
Immunicum
Kiromic
Merck
Northwest Biotherapeutics
Glaxo Smith Kline
ImmunoCellular
Tella
Vaxil Bio
Medigene
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
CreaVax
Sipuleucel-T (Provenge)
Others
Segment by Application
Pediatrics
Adults
Table of Contents
Executive Summary
1 Industry Overview of Dendritic Cell Cancer Vaccine
- 1.1 Definition of Dendritic Cell Cancer Vaccine
- 1.2 Dendritic Cell Cancer Vaccine Segment by Type
- 1.2.1 Global Dendritic Cell Cancer Vaccine Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 CreaVax
- 1.2.3 Sipuleucel-T (Provenge)
- 1.2.4 Others
- 1.3 Dendritic Cell Cancer Vaccine Segment by Applications
- 1.3.1 Global Dendritic Cell Cancer Vaccine Consumption Comparison by Applications (2014-2025)
- 1.3.2 Pediatrics
- 1.3.3 Adults
- 1.4 Global Dendritic Cell Cancer Vaccine Overall Market
- 1.4.1 Global Dendritic Cell Cancer Vaccine Revenue (2014-2025)
- 1.4.2 Global Dendritic Cell Cancer Vaccine Production (2014-2025)
- 1.4.3 North America Dendritic Cell Cancer Vaccine Status and Prospect (2014-2025)
- 1.4.4 Europe Dendritic Cell Cancer Vaccine Status and Prospect (2014-2025)
- 1.4.5 China Dendritic Cell Cancer Vaccine Status and Prospect (2014-2025)
- 1.4.6 Japan Dendritic Cell Cancer Vaccine Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Dendritic Cell Cancer Vaccine Status and Prospect (2014-2025)
- 1.4.8 India Dendritic Cell Cancer Vaccine Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Dendritic Cell Cancer Vaccine
- 2.3 Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine
- 2.4 Industry Chain Structure of Dendritic Cell Cancer Vaccine
3 Development and Manufacturing Plants Analysis of Dendritic Cell Cancer Vaccine
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Dendritic Cell Cancer Vaccine Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Dendritic Cell Cancer Vaccine
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Dendritic Cell Cancer Vaccine Production and Capacity Analysis
- 4.2 Dendritic Cell Cancer Vaccine Revenue Analysis
- 4.3 Dendritic Cell Cancer Vaccine Price Analysis
- 4.4 Market Concentration Degree
5 Dendritic Cell Cancer Vaccine Regional Market Analysis
- 5.1 Dendritic Cell Cancer Vaccine Production by Regions
- 5.1.1 Global Dendritic Cell Cancer Vaccine Production by Regions
- 5.1.2 Global Dendritic Cell Cancer Vaccine Revenue by Regions
- 5.2 Dendritic Cell Cancer Vaccine Consumption by Regions
- 5.3 North America Dendritic Cell Cancer Vaccine Market Analysis
- 5.3.1 North America Dendritic Cell Cancer Vaccine Production
- 5.3.2 North America Dendritic Cell Cancer Vaccine Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Dendritic Cell Cancer Vaccine Import and Export
- 5.4 Europe Dendritic Cell Cancer Vaccine Market Analysis
- 5.4.1 Europe Dendritic Cell Cancer Vaccine Production
- 5.4.2 Europe Dendritic Cell Cancer Vaccine Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Dendritic Cell Cancer Vaccine Import and Export
- 5.5 China Dendritic Cell Cancer Vaccine Market Analysis
- 5.5.1 China Dendritic Cell Cancer Vaccine Production
- 5.5.2 China Dendritic Cell Cancer Vaccine Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Dendritic Cell Cancer Vaccine Import and Export
- 5.6 Japan Dendritic Cell Cancer Vaccine Market Analysis
- 5.6.1 Japan Dendritic Cell Cancer Vaccine Production
- 5.6.2 Japan Dendritic Cell Cancer Vaccine Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Dendritic Cell Cancer Vaccine Import and Export
- 5.7 Southeast Asia Dendritic Cell Cancer Vaccine Market Analysis
- 5.7.1 Southeast Asia Dendritic Cell Cancer Vaccine Production
- 5.7.2 Southeast Asia Dendritic Cell Cancer Vaccine Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Dendritic Cell Cancer Vaccine Import and Export
- 5.8 India Dendritic Cell Cancer Vaccine Market Analysis
- 5.8.1 India Dendritic Cell Cancer Vaccine Production
- 5.8.2 India Dendritic Cell Cancer Vaccine Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Dendritic Cell Cancer Vaccine Import and Export
6 Dendritic Cell Cancer Vaccine Segment Market Analysis (by Type)
- 6.1 Global Dendritic Cell Cancer Vaccine Production by Type
- 6.2 Global Dendritic Cell Cancer Vaccine Revenue by Type
- 6.3 Dendritic Cell Cancer Vaccine Price by Type
7 Dendritic Cell Cancer Vaccine Segment Market Analysis (by Application)
- 7.1 Global Dendritic Cell Cancer Vaccine Consumption by Application
- 7.2 Global Dendritic Cell Cancer Vaccine Consumption Market Share by Application (2014-2019)
8 Dendritic Cell Cancer Vaccine Major Manufacturers Analysis
- 8.1 Medigene
- 8.1.1 Medigene Dendritic Cell Cancer Vaccine Production Sites and Area Served
- 8.1.2 Medigene Product Introduction, Application and Specification
- 8.1.3 Medigene Dendritic Cell Cancer Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Activarti
- 8.2.1 Activarti Dendritic Cell Cancer Vaccine Production Sites and Area Served
- 8.2.2 Activarti Product Introduction, Application and Specification
- 8.2.3 Activarti Dendritic Cell Cancer Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Argos Therapeutics
- 8.3.1 Argos Therapeutics Dendritic Cell Cancer Vaccine Production Sites and Area Served
- 8.3.2 Argos Therapeutics Product Introduction, Application and Specification
- 8.3.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Batavia Bioservices
- 8.4.1 Batavia Bioservices Dendritic Cell Cancer Vaccine Production Sites and Area Served
- 8.4.2 Batavia Bioservices Product Introduction, Application and Specification
- 8.4.3 Batavia Bioservices Dendritic Cell Cancer Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Bellicum Pharmaceuticals
- 8.5.1 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Production Sites and Area Served
- 8.5.2 Bellicum Pharmaceuticals Product Introduction, Application and Specification
- 8.5.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Creagene
- 8.6.1 Creagene Dendritic Cell Cancer Vaccine Production Sites and Area Served
- 8.6.2 Creagene Product Introduction, Application and Specification
- 8.6.3 Creagene Dendritic Cell Cancer Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 DanDrit Biotech
- 8.7.1 DanDrit Biotech Dendritic Cell Cancer Vaccine Production Sites and Area Served
- 8.7.2 DanDrit Biotech Product Introduction, Application and Specification
- 8.7.3 DanDrit Biotech Dendritic Cell Cancer Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 DCPrime
- 8.8.1 DCPrime Dendritic Cell Cancer Vaccine Production Sites and Area Served
- 8.8.2 DCPrime Product Introduction, Application and Specification
- 8.8.3 DCPrime Dendritic Cell Cancer Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Sanpower Corporation (Dendreon)
- 8.9.1 Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Production Sites and Area Served
- 8.9.2 Sanpower Corporation (Dendreon) Product Introduction, Application and Specification
- 8.9.3 Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Elios Therapeutics
- 8.10.1 Elios Therapeutics Dendritic Cell Cancer Vaccine Production Sites and Area Served
- 8.10.2 Elios Therapeutics Product Introduction, Application and Specification
- 8.10.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Immunicum
- 8.12 Kiromic
- 8.13 Merck
- 8.14 Northwest Biotherapeutics
- 8.15 Glaxo Smith Kline
- 8.16 ImmunoCellular
- 8.17 Tella
- 8.18 Vaxil Bio
- 8.19 Medigene
9 Development Trend of Analysis of Dendritic Cell Cancer Vaccine Market
- 9.1 Global Dendritic Cell Cancer Vaccine Market Trend Analysis
- 9.1.1 Global Dendritic Cell Cancer Vaccine Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Dendritic Cell Cancer Vaccine Regional Market Trend
- 9.2.1 North America Dendritic Cell Cancer Vaccine Forecast 2019-2025
- 9.2.2 Europe Dendritic Cell Cancer Vaccine Forecast 2019-2025
- 9.2.3 China Dendritic Cell Cancer Vaccine Forecast 2019-2025
- 9.2.4 Japan Dendritic Cell Cancer Vaccine Forecast 2019-2025
- 9.2.5 Southeast Asia Dendritic Cell Cancer Vaccine Forecast 2019-2025
- 9.2.6 India Dendritic Cell Cancer Vaccine Forecast 2019-2025
- 9.3 Dendritic Cell Cancer Vaccine Market Trend (Product Type)
- 9.4 Dendritic Cell Cancer Vaccine Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Dendritic Cell Cancer Vaccine Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Dendritic Cell Cancer Vaccine. Industry analysis & Market Report on Dendritic Cell Cancer Vaccine is a syndicated market report, published as Global Dendritic Cell Cancer Vaccine Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Dendritic Cell Cancer Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
